A Safety Extension Study With Benralizumab for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist
Public ClinicalTrials.gov record NCT02808819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open-label, Safety Extension Study With Benralizumab (MEDI-563) for Asthmatic Adults on Inhaled Corticosteroid Plus Long-acting β2 Agonist (MELTEMI)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to continue to characterize the safety profile of benralizumab administration and monitor the pharmacodynamic activity of the drug in those asthma patients who remain on treatment for at least 16 weeks and not more than 40 weeks in the predecessor study D3250C00021 (BORA, NCT02258542).
Study identification
- NCT ID
- NCT02808819
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 447 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 30, 2016 (Actual)
- Primary completion
- Jun 18, 2020 (Actual)
- Completion
- Jun 18, 2020 (Actual)
- Last update posted
- Apr 13, 2021
2016 – 2020
United States locations
- U.S. sites
- 52
- U.S. states
- 20
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Scottsboro | Alabama | 35768 | — |
| Research Site | Glendale | Arizona | 85306 | — |
| Research Site | Phoenix | Arizona | 85012 | — |
| Research Site | Bakersfield | California | 93301 | — |
| Research Site | Newport Beach | California | 92663 | — |
| Research Site | Redondo Beach | California | 90277 | — |
| Research Site | Roseville | California | 95661 | — |
| Research Site | Sacramento | California | 95825 | — |
| Research Site | San Jose | California | 95117 | — |
| Research Site | Stockton | California | 95204 | — |
| Research Site | Westminster | California | 92683 | — |
| Research Site | Woodland | California | 95695 | — |
| Research Site | Colorado Springs | Colorado | 80907 | — |
| Research Site | Denver | Colorado | 80206 | — |
| Research Site | Wheat Ridge | Colorado | 80033 | — |
| Research Site | New Haven | Connecticut | 06520 | — |
| Research Site | Clearwater | Florida | 33765 | — |
| Research Site | Doral | Florida | 33172 | — |
| Research Site | Hialeah | Florida | 33012 | — |
| Research Site | Miami | Florida | 33134 | — |
| Research Site | Miami | Florida | 33144 | — |
| Research Site | Miami | Florida | 33176 | — |
| Research Site | Orlando | Florida | 32819 | — |
| Research Site | Orlando | Florida | 32825 | — |
| Research Site | Winter Park | Florida | 32789 | — |
| Research Site | Iowa City | Iowa | 52242 | — |
| Research Site | Bangor | Maine | 04401 | — |
| Research Site | Quincy | Massachusetts | 02169 | — |
| Research Site | Farmington Hills | Michigan | 48334 | — |
| Research Site | Flint | Michigan | 48504 | — |
| Research Site | Traverse City | Michigan | 49686 | — |
| Research Site | New York | New York | 10016 | — |
| Research Site | The Bronx | New York | 10461 | — |
| Research Site | Durham | North Carolina | 27705 | — |
| Research Site | Winston-Salem | North Carolina | 27103 | — |
| Research Site | Cincinnati | Ohio | 45231 | — |
| Research Site | Middleburg Heights | Ohio | 44130 | — |
| Research Site | Oklahoma City | Oklahoma | 73103 | — |
| Research Site | Oklahoma City | Oklahoma | 73120 | — |
| Research Site | Jefferson Hills | Pennsylvania | 15025 | — |
| Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Research Site | Hodges | South Carolina | 29653 | — |
| Research Site | Rapid City | South Dakota | 57702 | — |
| Research Site | Dallas | Texas | 75225 | — |
| Research Site | Dallas | Texas | 75235 | — |
| Research Site | Houston | Texas | 77058 | — |
| Research Site | Houston | Texas | 77081 | — |
| Research Site | Houston | Texas | 77083 | — |
| Research Site | McKinney | Texas | 75069 | — |
| Research Site | Abingdon | Virginia | 24210 | — |
| Research Site | Falls Church | Virginia | 22044 | — |
| Research Site | Madison | Wisconsin | 53792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 126 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02808819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 13, 2021 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02808819 live on ClinicalTrials.gov.